Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study

Open Forum Infectious Diseases

Volumn 2, Issue 2, 2015, Pages

  Harris, Patrick N A ^a,b,c   Le, Bich Diep ^a   Tambyah, Paul ^a,b   Hsu, Li Yang ^a,b   Pada, Surinder ^a,b,d   Archuleta, Sophia ^a,b   Salmon, Sharon ^a   Mukhopadhyay, Amartya ^b   Dillon, Jasmine ^e   Ware, Robert ^e   Fisher, Dale A ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ALEXANDRA HOSPITAL   (Singapore)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Colonization; Methicillin resistant Staphylococcus aureus; MRSA; Octenidine; Topical antiseptics

Indexed keywords

OCTENIDINE;

ADULT; APACHE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84978327820     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv051     Document Type: Article

References (39)

1. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281-5.
2. Balm MN, Lover AA, Salmon S, et al. Progression from new methicillinresistant Staphylococcus aureus colonisation to infection: an observational study in a hospital cohort. BMC Infect Dis 2013; 13:491.
3. Pada SK, Ding Y, Ling ML, et al. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study. J Hosp Infect 2011; 78: 36-40.
4. Filice GA, Nyman JA, Lexau C, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2010; 31:365-73.
5. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States: U.S Department of Health and Human Services, 2013. Available at: http://www.cdc.gov/drugresistance/threat-report. Accessed 27 April, 2015.
6. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
7. Stamm AM, Long MN, Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 1993; 21:70-4.
8. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63(Suppl 1):S1-44.
9. Humphreys H. National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus-what do they tell us? Clin Microbiol Infect 2007; 13:846-53.
10. Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrugresistant organisms in health care settings, 2006. Am J Infect Control 2007; 35(10 Suppl 2):S165-93.
11. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005; 365:295-304.
12. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364:1407-18.
13. Kralovic SM, Evans ME, Simbartl LA, et al. Zeroing in on methicillinresistant Staphylococcus aureus: US Department of Veterans Affairs' MRSA Prevention Initiative. Am J Infect Control 2013; 41:456-8.
14. Fisher D, Tambyah PA, Lin RT, et al. Sustained meticillin-resistant Staphylococcus aureus control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore. J Hosp Infect 2013; 85:141-8.
15. Simor AE. Staphylococcal decolonisation: an effective strategy for prevention of infection? Lancet Infect Dis 2011; 11:952-62.
16. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
17. Gould IM, MacKenzie FM, MacLennan G, et al. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. Int J Antimicrob Agents 2007; 29:536-43.
18. Robicsek A, Beaumont JL, Thomson RB Jr, et al. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009; 30:623-32.
19. Ridenour G, Lampen R, Federspiel J, et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillinresistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007; 28:1155-61.
20. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9-17.
21. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255-65.
22. Sedlock DM, Bailey DM. Microbicidal activity of octenidine hydrochloride, a new alkanediylbis[pyridine] germicidal agent. Antimicrob Agents Chemother 1985; 28:786-90.
23. Rohr U, Mueller C, Wilhelm M, et al. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 2003; 54:305-9.
24. Spencer C, Orr D, Hallam S, Tillmanns E. Daily bathing with octenidine on an intensive care unit is associated with a lower carriage rate of meticillin-resistant Staphylococcus aureus. J Hosp Infect 2013; 83:156-9.
25. Krishna BV, Gibb AP. Use of octenidine dihydrochloride in meticillinresistant Staphylococcus aureus decolonisation regimens: a literature review. J Hosp Infect 2010; 74:199-203.
26. Koburger T, Hubner NO, Braun M, et al. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65:1712-9.
27. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters version 3.1. Available at: www.eucast.org. Accessed 27 April, 2015.
28. KnausWA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
30. Avery TR, Kleinman KP, Klompas M, et al. Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillinresistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2012; 33:114-21.
31. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364:703-5.
32. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171:216-9.
33. Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 2013; 95-b:4-9.
34. von EiffC, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11-6.
35. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; 4:CD006216.
36. Choudhury S, Krishnan PU, Ang B. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore. J Hosp Infect 2012; 82:56-7.
37. Al-Doori Z, Goroncy-Bermes P, Gemmell CG, Morrison D. Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 2007; 59:1280-1.
38. Otter JA, Patel A, CliffPR, et al. Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme. J Antimicrob Chemother 2013; 68:992-9.
39. Batra R, Cooper BS, Whiteley C, et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010; 50:210-7.